BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15892503)

  • 1. Treatments and devices for future diabetes management.
    Capaldi B
    Nurs Times; 2005 May 3-9; 101(18):30-2. PubMed ID: 15892503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of insulin secretagogues in the treatment of type 2 diabetes.
    Luna B; Hughes AT; Feinglos MN
    Prim Care; 1999 Dec; 26(4):895-915. PubMed ID: 10523467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus. Medication update.
    Slagle M
    South Med J; 2002 Jan; 95(1):50-5. PubMed ID: 11827245
    [No Abstract]   [Full Text] [Related]  

  • 4. Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
    Purnell JQ; Weyer C
    Treat Endocrinol; 2003; 2(1):33-47. PubMed ID: 15871553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatments for patients with type 2 diabetes mellitus.
    Wolffenbuttel BH; Graal MB
    Postgrad Med J; 1996 Nov; 72(853):657-62. PubMed ID: 8944206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seeking sweet relief for diabetes.
    Dove A
    Nat Biotechnol; 2002 Oct; 20(10):977-81. PubMed ID: 12355109
    [No Abstract]   [Full Text] [Related]  

  • 7. New pharmacological development (alpha glucosidase inhibitors, amylin analogues, GLP-1, thiozolidinediones, short acting insulin analogues).
    Dharmalingam M; Kumar P
    J Assoc Physicians India; 2001 Jan; 49 Spec No():46-9. PubMed ID: 11235605
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel strategies for the pharmacological management of type 2 diabetes.
    Nourparvar A; Bulotta A; Di Mario U; Perfetti R
    Trends Pharmacol Sci; 2004 Feb; 25(2):86-91. PubMed ID: 15102494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of diabetes mellitus. New developments and hopes].
    Verspohl EJ
    Med Monatsschr Pharm; 2005 Jun; 28(6):193-202; quiz 203. PubMed ID: 15960421
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel pharmacologic agents for type 2 diabetes.
    Uwaifo GI; Ratner RE
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):155-97. PubMed ID: 15752927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic treatment of diabetes].
    De Montigny P; Clerc C; Descarpentries C
    Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
    [No Abstract]   [Full Text] [Related]  

  • 13. Are you up-to-date on diabetes medications?
    Scemons D
    Nursing; 2007 Jul; 37(7):45-9; quiz 49-50. PubMed ID: 17603373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research advances in the treatment of type 2 diabetes mellitus.
    Caro J; Wishner KL
    Int J Clin Pract Suppl; 1999 Sep; 107():23-33. PubMed ID: 10692729
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological treatment of type 2 diabetes.
    Hermans MP; Buysschaert M
    Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological sheet. Vildagliptin, oral administration (GALVUS)].
    J Pharm Belg; 2009 Jun; (2):64-6. PubMed ID: 19739530
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
    Patel H; Srishanmuganathan J; Car J; Majeed A
    J Public Health (Oxf); 2007 Mar; 29(1):48-52. PubMed ID: 17124257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pharmacologic approaches to the treatment of diabetes.
    Johnson DG; Bressler R
    Spec Top Endocrinol Metab; 1984; 6():163-92. PubMed ID: 6151747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination therapy with biguanides].
    Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.
    Derosa G; Maffioli P; Ferrari I; Mereu R; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Salvadeo SA
    Horm Metab Res; 2010 Aug; 42(9):663-9. PubMed ID: 20560108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.